The combination of camrelizumab and apatinib obtained ongoing partial remission for a patient with osimertinib-resistant non-small cell lung cancer: case report
@article{APM52211, author = {Xiufeng Cong and Jun Chen and Wei Zheng}, title = {The combination of camrelizumab and apatinib obtained ongoing partial remission for a patient with osimertinib-resistant non-small cell lung cancer: case report}, journal = {Annals of Palliative Medicine}, volume = {10}, number = {3}, year = {2020}, keywords = {}, abstract = {}, issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/52211} }